Literature Citations
1. Synthesis and in Vitro Analysis of Novel Gallium tetrakis(4-methoxyphenyl)porphyrin and Its Long-acting Nanoparticle as a Potent Antimycobacterial Agent. Choi, S.R., B.E. Britigan, and P. Narayanasamy. Bioorganic & Medicinal Chemistry Letters, 2022. 62: 128645. PMID[35219822].
[PubMed]. TB_04_2022.
2. Discovery of a Novel Inhibitor Structure of Mycobacterium tuberculosis Isocitrate Lyase. Duan, C., Q. Jiang, X. Jiang, H. Zeng, Q. Wu, Y. Yu, and X. Yang. Molecules, 2022. 27(8): 2447. PMID[35458645]. PMCID[PMC9026967].
[PubMed]. TB_04_2022.
3. Synthesis and Antimycobacterial Evaluation of N-(4-(Benzyloxy)benzyl)-4-aminoquinolines. Grams, E.S., A. Silva Ramos, M. Neves Muniz, R.S. Rambo, M. Alberton Perelló, N. Sperotto, L. Calle González, L.S. Duarte, L. Galina, A. Silva Dadda, G. Arraché Gonçalves, C. Valim Bizarro, L.A. Basso, and P. Machado. Molecules, 2022. 27(8): 2556. PMID[35458755]. PMCID[PMC9027910].
[PubMed]. TB_04_2022.
4. Quinoline Derivatives as Potential Anti-tubercular Agents: Synthesis, Molecular Docking and Mechanism of Action. Liu, C.X., X. Zhao, L. Wang, and Z.C. Yang. Microbial Pathogenesis, 2022. 165: 105507. PMID[35354076].
[PubMed]. TB_04_2022.
5. Synthesis and in Vitro Biological Evaluation of Quinolinyl pyrimidines Targeting Type II NADH-dehydrogenase (NDH-2). Lu, L., L. Åkerbladh, S. Ahmad, V. Konda, S. Cao, A. Vocat, L. Maes, S.T. Cole, D. Hughes, M. Larhed, P. Brandt, A. Karlén, and S.L. Mowbray. ACS Infectious Diseases, 2022. 8(3): p. 482-498. PMID[35184552]. PMCID[PMC8922281].
[PubMed]. TB_04_2022.
6. Effects of Bedaquiline on Antimicrobial Activity and Cytokine Secretion of Macrophages Infected with Multidrug-resistant Mycobacterium tuberculosis Strains. Lyu, X.L., T.T. Lin, J.T. Gao, H.Y. Jia, C.Z. Zhu, Z.H. Li, J. Dong, Q. Sun, W. Shu, S.S. Wang, L.P. Pan, H.R. Huang, Z.D. Zhang, and Q. Li. Canadian Journal of Infectious Diseases and Medical Microbiology, 2022. 2022: 2703635. PMID[35449601]. PMCID[PMC9017561].
[PubMed]. TB_04_2022.
7. Acetylene Containing 2-(2-hydrazinyl)thiazole Derivatives: Design, Synthesis, and in Vitro and in Silico Evaluation of Antimycobacterial Activity against Mycobacterium tuberculosis. Maganti, L.H.B., D. Ramesh, B.G. Vijayakumar, M.I.K. Khan, A. Dhayalan, J. Kamalraja, and T. Kannan. RSC Advances, 2022. 12(14): p. 8771-8782. PMID[35424819]. PMCID[PMC8984819].
[PubMed]. TB_04_2022.
8. Chrysomycin A Inhibits the Topoisomerase I of Mycobacterium tuberculosis. Muralikrishnan, B., L.K. Edison, A. Dusthackeer, G.R. Jijimole, R. Ramachandran, A. Madhavan, and R.A. Kumar. The Journal of Antibiotics, 2022. 75(4): p. 226-235. PMID[35136191].
[PubMed]. TB_04_2022.
9. Identification of Potent DNA Gyrase Inhibitors Active against Mycobacterium tuberculosis. Pakamwong, B., P. Thongdee, B. Kamsri, N. Phusi, P. Kamsri, A. Punkvang, S. Ketrat, P. Saparpakorn, S. Hannongbua, K. Ariyachaokun, K. Suttisintong, S. Sureram, P. Kittakoop, P. Hongmanee, P. Santanirand, J. Spencer, A.J. Mulholland, and P. Pungpo. Journal of Chemical Information and Modeling, 2022. 62(7): p. 1680-1690. PMID[35347987].
[PubMed]. TB_04_2022.
10. In Vitro Biological Activity of Extracts from Marine Bacteria Cultures against Toxoplasma gondii and Mycobacterium tuberculosis. Quintero, M., L.M. Blandón, O.M. Vidal, J.D. Guzman, J.E. Gómez-Marín, A.D. Patiño, D.A. Molina, G.M. Puerto-Castro, and J. Gómez-León. Journal of Applied Microbiology, 2022. 132(4): p. 2705-2720. PMID[34856041].
[PubMed]. TB_04_2022.
11. First-in-class Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-diones against Leishmaniasis and Tuberculosis: Rationale, in Vitro, Ex Vivo Studies and Mechanistic Insights. Ramesh, D., D. Sarkar, A. Joji, M. Singh, A.K. Mohanty, G.V. B, M. Chatterjee, D. Sriram, S.K. Muthuvel, and T. Kannan. Archiv der Pharmazie, 2022. 355(4): e2100440. PMID[35106845].
[PubMed]. TB_04_2022.
12. Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents. Shi, R., B. Wang, G. Stelitano, X. Wu, Y. Shan, Y. Wu, X. Wang, L.R. Chiarelli, Y. Lu, and C. Qiao. ACS Medicinal Chemistry Letters, 2022. 13(4): p. 593-598. PMID[35450361]. PMCID[PMC9014434].
[PubMed]. TB_04_2022.
13. Mandelic acid-based Spirothiazolidinones Targeting M. tuberculosis: Synthesis, in Vitro and in Silico Investigations. Trawally, M., K. Demir-Yazıcı, S. Dingiş-Birgül, K. Kaya, A. Akdemir, and Ö. Güzel-Akdemir. Bioorganic Chemistry, 2022. 121: 105688. PMID[35189443].
[PubMed]. TB_04_2022.
14. Synthesis, anti-TB Activities, and Molecular Docking Studies of 4-(1,2,3-triazoyl)arylmethanone Derivatives. Turkmen, Y., G. Yagiz Erdemir, P. Yuksel Mayda, A. Akdemir, A. Gunaydin Akyildiz, and A. Altundas. Journal of Biochemical and Molecular Toxicology, 2022. 36(4): e22998. PMID[35187763].
[PubMed]. TB_04_2022.
Patent Citations
This month, no relevant Mycobacterium patents were identified.